PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
 
Proc R Soc Med. 1953 September; 46(9): 783–790.
PMCID: PMC1918661

Discussion on Some Biological Aspects of Mucin

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.3M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • GOTTSCHALK A. Carbohydrate residue of a urine mucoprotein inhibiting influenza virus haemagglutination. Nature. 1952 Oct 18;170(4329):662–663. [PubMed]
  • GOTTSCHALK A. Carbohydrate residue of a urine mucoprotein inhibiting influenza virus haemagglutination. Nature. 1952 Oct 18;170(4329):662–663. [PubMed]
  • TAMM I, HORSFALL FL., Jr A mucoprotein derived from human urine which reacts with influenza, mumps, and Newcastle disease viruses. J Exp Med. 1952 Jan;95(1):71–97. [PMC free article] [PubMed]
  • BARKSDALE WL, GHODA A. Agglutinins for Escherichia coli in serum and in fecal extracts from human enteritides and from hyperimmunized and epinephrine-stimulated rabbits. J Infect Dis. 1951 Jul-Aug;89(1):35–46. [PubMed]
  • FAZEKAS DE ST GROTH S. Studies in experimental immunology of influenza. IX. The mode of action of pathotopic adjuvants. Aust J Exp Biol Med Sci. 1951 Sep;29(5):339–351. [PubMed]
  • FAZEKAS DE ST GROTH S, DONNELLEY M, GRAHAM DM. Studies in experimental immunology of influenza. VIII. Pathotopic adjuvants. Aust J Exp Biol Med Sci. 1951 Sep;29(5):323–327. [PubMed]
  • Francis T., Jr THE INACTIVATION OF EPIDEMIC INFLUENZA VIRUS BY NASAL SECRETIONS OF HUMAN INDIVIDUALS. Science. 1940 Feb 23;91(2356):198–199. [PubMed]
  • KOSHLAND ME, BURROWS W. Quantitative studies of the relationship between fecal and serum antibody. J Immunol. 1950 Jul;65(1):93–103. [PubMed]
  • LAMBERT HP, RICHLEY J. The action of mucin in promoting infections: the anticomplementary effect of mucin extracts and certain other substances. Br J Exp Pathol. 1952 Aug;33(4):327–339. [PubMed]
  • Miller CP. EXPERIMENTAL MENINGOCOCCAL INFECTION IN MICE. Science. 1933 Oct 13;78(2024):340–341. [PubMed]
  • Morgan WT, King HK. Studies in immunochemistry: 7. The isolation from hog gastric mucin of the polysaccharide-amino acid complex possessing blood group A specificity. Biochem J. 1943;37(5):640–651. [PubMed]
  • Olitzki L. MUCIN AS A RESISTANCE-LOWERING SUBSTANCE. Bacteriol Rev. 1948 Jun;12(2):149–172. [PMC free article] [PubMed]
  • Smith H. The virulence-enhancing factor of mucins. 1. A biological assay of virulence-enhancing activity. Biochem J. 1950 Mar;46(3):352–356. [PubMed]
  • SMITH H, GALLOP RC. The acid polysaccharides of hog gastric mucosa. Biochem J. 1953 Mar;53(4):666–671. [PubMed]
  • SMITH H, ZWARTOUW HT, GALLOP RC, HARRIS-SMITH PW. The virulence-enhancing factor of mucins. 7. The remaining components of the third factor involved in virulence enhancement. Biochem J. 1953 Mar;53(4):673–678. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press